Your browser doesn't support javascript.
loading
The effect of burosumab on intact and C-terminal FGF23 measurements.
Ashrafzadeh-Kian, Susan Louise; Ito, Nobuaki; Srivastava, Tarak; Garg, Uttam; Kato, Hajime; Algeciras-Schimnich, Alicia; Bornhorst, Joshua A.
Afiliación
  • Ashrafzadeh-Kian SL; Department of Laboratory Medicine and Pathology, Mayo Clinic, Minnesota, Rochester, USA.
  • Ito N; Division of Nephrology and Endocrinology, The University of Tokyo Hospital, Tokyo, Japan.
  • Srivastava T; Department of Pediatrics, Section of Nephrology, Children's Mercy Hospital, Missouri, Kansas City, USA.
  • Garg U; Department of Pathology & Laboratory Medicine, Children's Mercy Hospital, Kansas City, Missouri, USA.
  • Kato H; Division of Nephrology and Endocrinology, The University of Tokyo Hospital, Tokyo, Japan.
  • Algeciras-Schimnich A; Department of Laboratory Medicine and Pathology, Mayo Clinic, Minnesota, Rochester, USA.
  • Bornhorst JA; Department of Laboratory Medicine and Pathology, Mayo Clinic, Minnesota, Rochester, USA.
Clin Endocrinol (Oxf) ; 99(2): 152-157, 2023 08.
Article en En | MEDLINE | ID: mdl-36263608

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Raquitismo Hipofosfatémico Familiar / Factores de Crecimiento de Fibroblastos Límite: Humans Idioma: En Revista: Clin Endocrinol (Oxf) Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Raquitismo Hipofosfatémico Familiar / Factores de Crecimiento de Fibroblastos Límite: Humans Idioma: En Revista: Clin Endocrinol (Oxf) Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos